Evaluating the effectiveness of a comprehensive chronic disease management service focused on primary care for hypertension and diabetes patients in real-world settings: a community-based clinical study

Not Applicable

Recruiting

• Conditions: Diseases of the circulatory system

• Registration Number: KCT0007910
• Lead Sponsor: The Catholic University of Korea

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 950

Inclusion Criteria

? Patients with diabetes
- Type 2 diabetes
- Over 19 years old and 75 years old
- HbA1c 7.0% or higher at baseline
- Those who have consented to participate in this clinical trial and have given their written consent

? Patients with hypertension
- Essential hypertension
- Over 19 years old and 75 years old
- Mean sitting systolic and diastolic blood pressure at baseline
: Mean sitting systolic blood pressure (MSSBP): 140 mmHg or more and less than 180 mmHg
: Mean sitting diastolic blood pressure (MSDBP): less than 110 mmHg
- Those who have consented to participate in this clinical trial and have given their written consent

Exclusion Criteria

? Patients with diabetes
- Receiving insulin pump treatment
- Severe renal disease: eGFR<30ml/min
- Heart function falls under New Your Heart Association III-IV
- Diagnosed with a malignant tumor within the past 5 years and have not completed treatment
- Taking systemic steroids or immunosuppressants that affect blood sugar control
- Pregnant or lactating
- Judged inappropriate to participate in the study due to general weakness, etc.

? Patients with hypertension
- Taking 3 or more antihypertensive medications at baseline
- History of secondary hypertension or suspected secondary hypertension
- Symptomatic orthostatic hypotension
- History of cerebral infarction
- History of myocardial infarction or unstable angina
- Undergone percutaneous coronary intervention (PCI) or coronary artery replacement surgery
- Severe heart disease: Heart failure (NYHA grade III ~ IV)
- Clinically significant arrhythmia
- Cardiomyopathy
- Severe kidney or liver disease
- Diagnosed with a malignant tumor within the past 5 years and have not completed treatment
- Pregnant or lactating
- Judged inappropriate to participate in the study due to general weakness, etc.

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients with diabetes : Differences in HbA1c change at 1 and 2 years compared to baseline;Patients with hypertension : Differences in SBP change at 1 and 2 years compared to baseline